Related Experiment Video
Updated: Dec 27, 2025

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
Published on: August 11, 2023
CYP3A4 and CYP11A1 variants are risk factors for ischemic stroke: a case control study
Ning Gao1, Hong Tang1, Ling Gao1
1Department of Neurosurgery, Affiliated Haikou Hospital of Xiangya Medical College of Central South University, Haikou People's Hospital, #43, People's Avenue, Haidian Island, Haikou, 570208, Hainan, China.
Insights
Genetic variants in CYP3A4 and CYP11A1 influence ischemic stroke (IS) risk in the Han Chinese population. Certain CYP3A4 and CYP11A1 polymorphisms may offer protection against IS, while others increase susceptibility.
Area of Science:
- Genetics
- Cardiovascular Science
- Pharmacogenomics
Background:
- Ischemic stroke (IS) poses a significant health burden.
- Understanding genetic predispositions is crucial for risk stratification.
- Cytochrome P450 enzymes, including CYP3A4 and CYP11A1, play roles in various physiological processes.
Purpose of the Study:
- To investigate the association between specific single-nucleotide polymorphisms (SNPs) in CYP3A4 and CYP11A1 genes and the susceptibility to ischemic stroke.
- To explore potential sex- and age-specific effects of these genetic variants on IS risk.
Main Methods:
- A case-control study involving 477 IS patients and 493 healthy controls from the Han Chinese population.
- Genotyping of seven selected SNPs in CYP3A4 and CYP11A1 using Agena MassARRAY.
- Statistical analysis using logistic regression to calculate odds ratios (OR) and 95% confidence intervals (CI), adjusted for age and gender.
Main Results:
- CYP3A4 variants rs3735451 and rs4646440 were associated with a decreased risk of IS.
- CYP3A4 rs4646440 and CYP11A1 rs12912592 showed associations with IS risk in males.
- Protective effects of CYP3A4 rs3735451 and rs4646440 were observed in individuals over 61 years old.
- Specific variants in CYP3A4 and CYP11A1 were linked to IS risk in individuals aged 61 years or younger.
- CYP11A1 rs28681535 genotype correlated with higher high-density lipoprotein cholesterol levels.
Conclusions:
- Specific polymorphisms in CYP3A4 (rs3735451, rs4646440, rs4646437) and CYP11A1 (rs28681535) may act as protective factors against ischemic stroke in the Han Chinese population.
- The CYP11A1 rs12912592 polymorphism was identified as a potential risk factor for IS in this population.
- These findings highlight the potential role of pharmacogenomic variations in IS susceptibility.
Background:
This study aimed to investigate the roles of CYP3A4 and CYP11A1 variants in ischemic stroke (IS) susceptibility among the Han Chinese population.
Methods:
Four hundred seventy-seven patients with IS and 493 healthy controls were enrolled. Seven single-nucleotide polymorphisms (SNPs) of CYP3A4 and CYP11A1 were genotyped by Agena MassARRAY. Odds ratio (OR) and 95% confidence intervals (CI) were calculated by logistic regression adjusted for age and gender.
Results:
We found that CYP3A4 rs3735451 (OR = 0.81, p = 0.039) and rs4646440 (OR = 0.72, p = 0.021) polymorphisms decreased the risk of IS. CYP3A4 rs4646440 (OR = 0.74, p = 0.038) and CYP11A1 rs12912592 (OR = 1.58, p = 0.034) polymorphisms were correlated with IS risk in males. CYP3A4 rs3735451 (OR = 0.63, p = 0.031) and rs4646440 (OR = 0.57, p = 0.012) possibly weaken the IS susceptibility at age > 61 years. Besides, CYP3A4 rs4646437 (OR = 0.59, p = 0.029), CYP11A1 rs12912592 (OR = 1.84, p = 0.017) and rs28681535 (OR = 0.66, p = 0.038) were associated with IS risk at age ≤ 61 years. CYP11A1 rs28681535 TT genotype was higher high-density lipoprotein cholesterol level than the GT and GG genotype (p = 0.027).
Conclusions:
Our findings indicated that rs3735451, rs4646440, rs4646437 in CYP3A4 and rs28681535 in CYP11A1 might be protective factors for IS, while CYP11A1 rs12912592 polymorphism be a risk factor for IS in Chinese Han population.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Coronary Artery Disease IV: Preventive Measures

